Skip to main content
. 2020 Jan 21;174(4):385–387. doi: 10.1001/jamapediatrics.2019.5526

Table 2. Marketing of Stimulant Products According to Medical Specialty, per the Open Payment Program Database (January 1, 2014, to December 31, 2018).

Physician Specialty Payments, No. (%) Total Payment Amount, $ (%) Payment, Median (IQR), $ Unique Physicians, No. (%)a Total Active Physicians, No. (%)b Estimated 5-y Prevalence, %
Pediatrics 239 217 (40.4) 5 003 379 (24.9) 14 (12-18) 17 427 (31.6) 90 766 (9.2) 19.2
Psychiatry 188 076 (31.8) 11 392 037 (56.7) 15 (12-19) 9660 (17.5) 54 895 (5.5) 17.6
Family medicine 106 615 (18.0) 2 138 459 (10.6) 14 (12-16) 17 048 (30.9) 136 604 (13.8) 12.5
Internal medicine 32 531 (5.5) 825 003 (4.1) 14 (12-17) 7213 (13.1) 272 060 (27.4) 2.7
Neurology 20 077 (3.4) 637 634 (3.2) 15 (12-19) 1235 (2.2) 20 974 (2.1) 5.9
Otherc 5391 (0.9) 104 738 (0.5) 14 (12-17) 2522 (4.6) 416 440 (42.0) 0.6

Abbreviation: IQR, interquartile range.

a

Overall, 55 105 unique physicians received marketing.

b

Estimated using National Provider Identifier data from 2014 to 2018.6

c

Includes anesthesiology, dermatology, emergency medicine, general surgery and subspecialties, obstetrics and gynecology, orthopedic surgery, otorhinolaryngology, pain medicine, physical medicine and rehabilitation, and physicians from other specialties.